Cell Systems

Kirkland, United States Founded: 1989 • Age: 37 yrs Acquired By Anabios
Primary cells, culture media, and reagents are developed and manufactured.
Request Access

About Cell Systems

Cell Systems is a company based in Kirkland (United States) founded in 1989 by Carl Soderland was acquired by Anabios in April 2023.. Cell Systems has raised $200 thousand across 1 funding round from investors including Anabios. Cell Systems offers products and services including Primary Cells, Cell Culture Media, Reagents, Tissue Samples, and All-In-One Kits. Cell Systems operates in a competitive market with competitors including BioLife Solutions, RoosterBio, Shanghai Doning Biotechnology, Polyplus Transfection and Prolific Machines, among others.

  • Headquarter Kirkland, United States
  • Founders Carl Soderland
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $200 K (USD)

    in 1 rounds

  • Latest Funding Round
    $200 K (USD), Unspecified

    May 26, 2017

  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Anabios

    (Apr 04, 2023)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Cell Systems

Cell Systems offers a comprehensive portfolio of products and services, including Primary Cells, Cell Culture Media, Reagents, Tissue Samples, and All-In-One Kits. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

High-viability cells for advanced research experiments.

Nutrient media to support cell growth and viability.

Chemicals designed for cell biology research needs.

Samples for studying cellular structures and functions.

Comprehensive kits for optimized cell culture experiments.

Funding Insights of Cell Systems

Cell Systems has successfully raised a total of $200K through 1 strategic funding round. The most recent funding activity was a Unspecified round of $200 thousand completed in May 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Unspecified — $200,000
  • First Round

    (26 May 2017)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2017 Amount Unspecified - Cell Systems Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Cell Systems

Cell Systems has secured backing from 1 investor. Prominent investors backing the company include Anabios. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
Ex-vivo human tissue studies are performed for preclinical drug discovery.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Cell Systems

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Cell Systems

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Cell Systems Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Cell Systems

Cell Systems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BioLife Solutions, RoosterBio, Shanghai Doning Biotechnology, Polyplus Transfection and Prolific Machines, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Tissue hypothermic storage and cryopreservation freeze media are developed.
domain founded_year HQ Location
Developer of human mesenchymal stem cells and extracellular vesicles
domain founded_year HQ Location
Serum-free cell culture media is supplied to biopharmaceutical industries.
domain founded_year HQ Location
Transfection Solutions for Healthcare and Life Sciences organizations
domain founded_year HQ Location
Photomolecular biology platform is provided for controlling cellular functions dynamically.
domain founded_year HQ Location
Neural exosome platform is developed for neurodegenerative disease therapeutics.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Cell Systems

Frequently Asked Questions about Cell Systems

When was Cell Systems founded?

Cell Systems was founded in 1989 and raised its 1st funding round 28 years after it was founded.

Where is Cell Systems located?

Cell Systems is headquartered in Kirkland, United States. It is registered at Kirkland, Washington, United States.

Is Cell Systems a funded company?

Cell Systems is a funded company, having raised a total of $200K across 1 funding round to date. The company's 1st funding round was a Unspecified of $200K, raised on May 26, 2017.

What does Cell Systems do?

Cell Systems is focused on developing primary cells, cell culture media reagents for the cell biology. They offer around 30 types of primary human cell types their complete medium kits for mesenchymal cells and cell lines, including human cells, embryonic and adult stem cells, etc. They also provide reagents for all steps of cell culture and cryopreservation. In addition, they are developing 3D cultures.

Who are the top competitors of Cell Systems?

Cell Systems's top competitors include FabricNano, RoosterBio and Prolific Machines.

What products or services does Cell Systems offer?

Cell Systems offers Primary Cells, Cell Culture Media, Reagents, Tissue Samples, and All-In-One Kits.

Who are Cell Systems's investors?

Cell Systems has 1 investor. Key investors include Anabios.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available